Policy Prolia’s drug price cut 30% before the entry of biosimilars by Lee, Tak-Sun Sep 3, 2024 05:53am
Company Biological drug options for psoriasis treatment increase by Son, Hyung-Min Sep 2, 2024 05:48am
Company Yuhan’s Leclaza targets US mkt based on its clinical effect by Hwang, Byung-woo Sep 2, 2024 05:48am
Policy Nicergoline for dementia listed at 50% of the highest-priced by Lee, Tak-Sun Sep 2, 2024 05:48am
Policy Lily's orphan drug 'Jaypirca' receives conditional approval by Lee, Hye-Kyung Aug 30, 2024 05:50am